Date Filed | Type | Description |
08/08/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2022 |
SC 13G/A
| Corriente Advisors, LLC reports a 0% stake in Cue Biopharma, Inc. |
02/14/2022 |
SC 13G/A
| Corriente Advisors, LLC reports a 0% stake in TFF Pharmaceuticals, Inc. |
02/14/2022 |
SC 13G/A
| Corriente Advisors, LLC reports a 0% stake in Cardiff Oncology, Inc. |
11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/18/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/16/2021 |
SC 13G
| Corriente Advisors, LLC reports a 6.1% stake in TFF Pharmaceuticals, Inc. |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G
| Corriente Advisors, LLC reports a 5.7% stake in Cardiff Oncology, Inc. |
11/03/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/18/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/23/2020 |
SC 13G
| Corriente Advisors, LLC reports a 6.1% stake in Nautilus, Inc. |
11/26/2019 |
SC 13G/A
| Corriente Advisors, LLC reports a 4.9% stake in Maxar Technologies Inc. |
11/20/2019 |
SC 13G
| Corriente Advisors, LLC reports a 5% stake in Maxar Technologies Inc. |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/23/2018 |
SC 13G
| Corriente Advisors, LLC reports a 7.3% stake in Catabasis Pharmaceuticals, Inc. |
11/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
05/15/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
02/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
11/14/2012 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
08/14/2012 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
|